This activity is expired and is no longer available for CME credit.


What Is Cardiovascular Risk With Anti-VEGF Drugs?

Author(s)/Faculty: Andrew P. Schachat, MD
Release Date: 2/20/2013Expiration Date: 1/28/2017
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Discussion of the risk of cardiovascular disease for patients receiving anti–vascular endothelial growth factor (anti-VEGF) drugs for age-related macular degeneration.